FDA Approved: ADDYI — Original Application (Sprout Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ADDYI (flibanserin) in Sprout Pharmaceuticals' original NDA for hypoactive sexual desire disorder in premenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• ADDYI (flibanserin)

Snippet

ORIG AP for ADDYI (FLIBANSERIN)